Near Patient Molecular Solution Market – Global Industry Analysis 2024

Near patient molecular solution, also referred as point-of-care diagnosis, is a technology which helps diagnosis and monitoring health at the convenience of patient. There are many innovations in healthcare technologies like smartphone apps, wearable devices and biosensors which provide ease to patient in monitoring their health. The driving concept is to bring testing near to patient and provide quick and appropriate result. This technique offers convenience, and quick results compared to the traditional lab-based tests.

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/47

Increasing incidence of diseases such as cardiac disorders and diabetes in developing countries, increase in the practice of home based point of care devices, advancement in technology and easy to use devices are motivating the point of care diagnostic market. According to the institute for Health Metrics and Evaluation (IHME), globally the number of deaths due to cardiovascular diseases increased by 41% between 1990 and 2013 climbing from 12.3 million to 17.3 million deaths. South Asia experienced the largest jump in total death with 1.8 million more deaths in 2013 than in 1990 – an increase of 97%.

Due to the increasing demand for point of care diagnosis, manufacturing companies are focusing on quick results, easy-to-use and more reliable technologies. However shortage of skilled staff in using these devices is expected to restrain the market growth for near patient or point of care diagnostic devices.

Market Taxonomy near Patient Molecular Solution Segmentation

Based on technology, the near patient molecular solution market is segmented as following:

PCR based: Idylla is a real time PCR based molecular diagnostic system which is designed in such a way that physicians get fast access to highly reliable clinical molecular diagnostic information. Treatments become more targeted to individual patient by personalized medicine.

Genetic Sequencing based: platforms are available which enables genetic sequencing and analysis of DNA data at point of care with high accuracy. Rapid DNA analysis is expected to grow in the near future.

Hybridization based: Peptide Nucleic Acid (PNA) molecular beacon probe is used to quantify 16SrRNA of specific populations in RNA extract of environmental samples.

Based on the applications, the global near patient molecular solution market is segmented as infectious diseases testing kits, pregnancy and fertility kits, hematology testing kits, urinalysis testing kits and glucose monitoring kits. Infectious disease kits can further be analyzed into tuberculosis, human immunodeficiency virus (HIV), hepatitis, and malaria.

Near Patient Molecular Solutions also benefit the Physicians at Hospitals and Private Clinics

End users of near patient molecular solution or POC devices include hospitals, homecare, research laboratories and diagnostic laboratories. Use of near patient molecular solutions benefits the physicians at outpatient care with quicker turnaround time. Also, the need to wait for the results through a traditional laboratory testing method is avoided using the near patient diagnostic solution.

Market of Near Patient in Different Regions

North America has a potential market for molecular diagnostics kits used in the testing of infectious diseases. This is because of technological advancement in molecular diagnostic tools, high prevalence of infectious diseases, high patient awareness and faster adoption of these devices. The market in Asia will grow due to research and development activities, growing awareness among people about infectious diseases and their diagnostic procedures. Moreover, increase in population and disposable income in developing countries like India and China are expected to boost the growth in near patient molecular diagnostics.

Browse Research Report At : https://www.coherentmarketinsights.com/ongoing-insight/near-patient-molecular-solution-market-47

Market Players to focus on Device Accuracy and Quickness to Deliver Results

The major companies operating in the global molecular diagnostics are Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp. and GenMark Diagnostics. Advance technology is the major focus of companies competing in this market as quick and accurate results generate demand for these devices. Abbott’s i-STAT Alinity handheld blood testing platform received CE mark in November 2016. Siemens Healthineers acquired Conworx Technology to flesh out its point-of-care informatics capabilities in November 2016.

ABOUT US
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US
CORPORATE OFFICE :
Coherent Market Insights
303, Astral Court,Above Reliance Fresh,
Near Gaikwad Petrol Pump,
Aundh, Pune – 411045, India
Mail Id : sales@coherentmarketinsights.com
Visit Blog : http://globalresearchtrends.blogspot.in/

This release was published on openPR.